Provided by Tiger Trade Technology Pte. Ltd.

SHANDONG XINHUA

6.950
+0.0500.72%
Volume:1.55M
Turnover:10.90M
Market Cap:4.84B
PE:9.07
High:7.150
Open:6.900
Low:6.880
Close:6.900
52wk High:9.460
52wk Low:4.895
Shares:697.00M
HK Float Shares:195.00M
Volume Ratio:1.95
T/O Rate:0.80%
Dividend:0.28
Dividend Rate:4.05%
EPS(LYR):0.766
ROE:7.59%
ROA:3.06%
PB:0.84
PE(LYR):9.07
PS:0.51

Loading ...

Shandong Xinhua Pharmaceutical (00719) Terminates Equity Acquisition Intention with NovoSana (Europe) B.V.

Bulletin Express
·
Feb 06

Shandong Xinhua Pharmaceutical Calls Off Planned Acquisition of Nuoya Shengnuo (Taicang) Stake

Stock News
·
Feb 06

Shandong Xinhua (00719) Announces January 2026 Share Capital Movements

Bulletin Express
·
Feb 02

Shandong Xinhua Pharmaceutical (00719) Cancels Total of 1.057 Million Granted but Unexercised Stock Options

Stock News
·
Jan 20

SHANDONG XINHUA (00719) Grants 6.9069 Million A-Shares Under 2021 Stock Option Incentive Plan

Stock News
·
Jan 14

SHANDONG XINHUA (00719) Secures Drug Registration Certificate for Phloroglucinol Injection

Stock News
·
Dec 29, 2025

Xinhua Pharmaceutical Gets Registration Certificate for Influenza Drug in China

MT Newswires Live
·
Dec 23, 2025

AH Share Premium Rate and Deviation Rankings as of December 3

Stock News
·
Dec 03, 2025

AH Share Premium Rate Rankings as of December 1

Stock News
·
Dec 01, 2025

Shandong Xinhua Pharmaceutical (00719) Announces Monthly Return for November 2025

Bulletin Express
·
Dec 01, 2025

AH Share Premium Rate and Deviation Rankings as of November 28

Stock News
·
Nov 28, 2025

Xinhua Pharmaceutical Gets China Nod for Inflammatory Disease Drug-Related Marketing

MT Newswires Live
·
Nov 27, 2025

Xinhua Pharmaceutical's Dyspnea Drug Passes Chinese Regulator's Consistency Evaluation

MT Newswires Live
·
Nov 27, 2025

Xinhua Pharmaceutical (00719.HK / 000756.SZ) Announces Epinephrine Hydrochloride Injection Passes Generic Consistency Evaluation

Bulletin Express
·
Nov 27, 2025

Xinhua Pharmaceutical (00719.HK/000756.SZ) Receives Approval for Prednisolone Acetate

Bulletin Express
·
Nov 27, 2025

SHANDONG XINHUA (00719) Receives Approval Notice for Prednisolone Acetate API Marketing Application

Stock News
·
Nov 27, 2025

AH Premium Rate and Deviation Rankings as of November 26

Stock News
·
Nov 26, 2025

Xinhua Pharmaceutical Obtains Registration Certificate for Local Skin Anesthesia Drug

MT Newswires Live
·
Nov 25, 2025

HK Stock Movement | SHANDONG XINHUA (00719) Rises Over 4% as Lidocaine and Prilocaine Cream Gains Approval

Stock News
·
Nov 25, 2025

Here's Why Shandong Xinhua Pharmaceutical (HKG:719) Can Manage Its Debt Responsibly

Simply Wall St.
·
Nov 22, 2025